{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T06:39:13Z","timestamp":1789799953930,"version":"4.0.1"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Graduate Education Innovation Program of Guizhou University of Chinese Medicine","award":["YCXKYB2023008"],"award-info":[{"award-number":["YCXKYB2023008"]}]},{"name":"Chinese Ethnic Medicine Association research project","award":["2023ZY176-53"],"award-info":[{"award-number":["2023ZY176-53"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460911"],"award-info":[{"award-number":["82460911"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474238"],"award-info":[{"award-number":["82474238"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02038-z","type":"journal-article","created":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T21:03:55Z","timestamp":1746047035000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Shared genetic association between inflammatory bowel disease and acute myeloid leukemia: insights from mendelian randomization and transcriptomic analyses"],"prefix":"10.1007","volume":"74","author":[{"given":"Yanqun","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongfeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangjin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zenghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,30]]},"reference":[{"key":"2038_CR1","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.1038\/s41467-021-26551-x","volume":"12","author":"WY Lin","year":"2021","unstructured":"Lin WY, et al. Genome-wide association study identifies susceptibility loci for acute myeloid leukemia. Nat Commun. 2021;12:6233. https:\/\/doi.org\/10.1038\/s41467-021-26551-x.","journal-title":"Nat Commun"},{"key":"2038_CR2","doi-asserted-by":"publisher","first-page":"108963","DOI":"10.1016\/j.cbi.2020.108963","volume":"317","author":"XL Liu","year":"2020","unstructured":"Liu XL, et al. Role of epigenetic in leukemia: from mechanism to therapy. Chem Biol Interact. 2020;317:108963. https:\/\/doi.org\/10.1016\/j.cbi.2020.108963.","journal-title":"Chem Biol Interact"},{"key":"2038_CR3","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1172\/jci129204","volume":"130","author":"L Vago","year":"2020","unstructured":"Vago L, Gojo I. Immune escape and immunotherapy of acute myeloid leukemia. J Clin Investig. 2020;130:1552\u201364. https:\/\/doi.org\/10.1172\/jci129204.","journal-title":"J Clin Investig"},{"key":"2038_CR4","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/cncr.33458","volume":"127","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, et al. De novo acute myeloid leukemia: a population-based study of outcome in the United States based on the Surveillance, Epidemiology, and End Results (SEER) database, 1980 to 2017. Cancer. 2021;127:2049\u201361. https:\/\/doi.org\/10.1002\/cncr.33458.","journal-title":"Cancer"},{"key":"2038_CR5","doi-asserted-by":"publisher","first-page":"1000996","DOI":"10.3389\/fimmu.2022.1000996","volume":"13","author":"M Luciano","year":"2022","unstructured":"Luciano M, Krenn PW, Horejs-Hoeck J. The cytokine network in acute myeloid leukemia. Front Immunol. 2022;13:1000996. https:\/\/doi.org\/10.3389\/fimmu.2022.1000996.","journal-title":"Front Immunol"},{"key":"2038_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s43018-022-00480-0","volume":"4","author":"A Lasry","year":"2023","unstructured":"Lasry A, et al. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia. Nat Cancer. 2023;4:27\u201342. https:\/\/doi.org\/10.1038\/s43018-022-00480-0.","journal-title":"Nat Cancer"},{"key":"2038_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1182\/bloodadvances.2021004962","volume":"6","author":"S Stratmann","year":"2022","unstructured":"Stratmann S, et al. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Adv. 2022;6:152\u201364. https:\/\/doi.org\/10.1182\/bloodadvances.2021004962.","journal-title":"Blood Adv"},{"key":"2038_CR8","doi-asserted-by":"publisher","DOI":"10.1172\/jci152673","author":"Y Mei","year":"2022","unstructured":"Mei Y, et al. Bone marrow-confined IL-6 signaling mediates the progression of myelodysplastic syndromes to acute myeloid leukemia. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/jci152673.","journal-title":"J Clin Invest"},{"key":"2038_CR9","doi-asserted-by":"publisher","DOI":"10.5009\/gnl240119","author":"X Zhou","year":"2024","unstructured":"Zhou X, et al. Risk of hematologic malignancies in patients with inflammatory bowel disease: a meta-analysis of cohort studies. Gut Liver. 2024. https:\/\/doi.org\/10.5009\/gnl240119.","journal-title":"Gut Liver"},{"key":"2038_CR10","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12185-014-1506-1","volume":"99","author":"T Sakai","year":"2014","unstructured":"Sakai T, et al. Development of myeloid sarcoma after long-term methotrexate use for rheumatoid arthritis. Int J Hematol. 2014;99:493\u20138. https:\/\/doi.org\/10.1007\/s12185-014-1506-1.","journal-title":"Int J Hematol"},{"key":"2038_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/1744666x.2018.1519394","volume":"14","author":"A Ladouceur","year":"2018","unstructured":"Ladouceur A, Bernatsky S, Ramsey-Goldman R, Clarke AE. Managing cancer risk in patients with systemic lupus erythematous. Expert Rev Clin Immunol. 2018;14:793\u2013802. https:\/\/doi.org\/10.1080\/1744666x.2018.1519394.","journal-title":"Expert Rev Clin Immunol"},{"key":"2038_CR12","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1053\/j.gastro.2021.07.042","volume":"161","author":"G Rogler","year":"2021","unstructured":"Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161:1118\u201332. https:\/\/doi.org\/10.1053\/j.gastro.2021.07.042.","journal-title":"Gastroenterology"},{"key":"2038_CR13","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00011-023-01836-7","volume":"73","author":"L Cao","year":"2024","unstructured":"Cao L, et al. Global evolving patterns and cross-country inequalities of inflammatory bowel disease burden from 1990 to 2019: a worldwide report. Inflamm Res. 2024;73:277\u201387. https:\/\/doi.org\/10.1007\/s00011-023-01836-7.","journal-title":"Inflamm Res"},{"key":"2038_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/s2468-1253(16)30077-2","volume":"1","author":"GG Kaplan","year":"2016","unstructured":"Kaplan GG, Ng SC. Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China. Lancet Gastroenterol Hepatol. 2016;1:307\u201316. https:\/\/doi.org\/10.1016\/s2468-1253(16)30077-2.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2038_CR15","doi-asserted-by":"publisher","first-page":"100458","DOI":"10.1016\/j.lrr.2024.100458","volume":"21","author":"DM Mueller","year":"2024","unstructured":"Mueller DM, Nathan DI, Liu A, Mascarenhas J, Marcellino BK. Myeloid neoplasms in inflammatory bowel disease: a case series and review of the literature. Leuk Res Rep. 2024;21:100458. https:\/\/doi.org\/10.1016\/j.lrr.2024.100458.","journal-title":"Leuk Res Rep"},{"key":"2038_CR16","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.gtc.2022.05.003","volume":"51","author":"AS Faye","year":"2022","unstructured":"Faye AS, Holmer AK, Axelrad JE. Cancer in inflammatory bowel disease. Gastroenterol Clin North Am. 2022;51:649\u201366. https:\/\/doi.org\/10.1016\/j.gtc.2022.05.003.","journal-title":"Gastroenterol Clin North Am"},{"key":"2038_CR17","doi-asserted-by":"publisher","first-page":"1338918","DOI":"10.3389\/fimmu.2023.1338918","volume":"14","author":"H Zhang","year":"2023","unstructured":"Zhang H, et al. Overcoming cancer risk in inflammatory bowel disease: new insights into preventive strategies and pathogenesis mechanisms including interactions of immune cells, cancer signaling pathways, and gut microbiota. Front Immunol. 2023;14:1338918. https:\/\/doi.org\/10.3389\/fimmu.2023.1338918.","journal-title":"Front Immunol"},{"key":"2038_CR18","doi-asserted-by":"publisher","first-page":"636791","DOI":"10.3389\/fsurg.2021.636791","volume":"8","author":"Z Geng","year":"2021","unstructured":"Geng Z, Geng Q. Risk of urinary bladder cancer in patients with inflammatory bowel diseases: a meta-analysis. Front Surg. 2021;8:636791. https:\/\/doi.org\/10.3389\/fsurg.2021.636791.","journal-title":"Front Surg"},{"key":"2038_CR19","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1093\/jcag\/gwad006","volume":"6","author":"SK Murthy","year":"2023","unstructured":"Murthy SK, et al. The 2023 impact of inflammatory bowel disease in canada: cancer and IBD. J Can Assoc Gastroenterol. 2023;6:S83-s96. https:\/\/doi.org\/10.1093\/jcag\/gwad006.","journal-title":"J Can Assoc Gastroenterol"},{"key":"2038_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.14309\/ajg.0000000000001058","volume":"116","author":"N Khan","year":"2021","unstructured":"Khan N, et al. Incidence of acute myeloid leukemia and myelodysplastic syndrome in patients with inflammatory bowel disease and the impact of thiopurines on their risk. Am J Gastroenterol. 2021;116:741\u20137. https:\/\/doi.org\/10.14309\/ajg.0000000000001058.","journal-title":"Am J Gastroenterol"},{"key":"2038_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/diseases11020059","volume":"11","author":"A Bangolo","year":"2023","unstructured":"Bangolo A, et al. Association between multiple myeloma and ulcerative colitis: A cross-sectional analysis. Diseases. 2023;11:59. https:\/\/doi.org\/10.3390\/diseases11020059.","journal-title":"Diseases"},{"key":"2038_CR22","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.mayocp.2015.03.024","volume":"90","author":"S Yadav","year":"2015","unstructured":"Yadav S, et al. Effect of medications on risk of cancer in patients with inflammatory bowel diseases: a population-based cohort study from olmsted county. Minnesota. 2015;90:738\u201346. https:\/\/doi.org\/10.1016\/j.mayocp.2015.03.024.","journal-title":"Minnesota"},{"key":"2038_CR23","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cgh.2020.08.015","volume":"19","author":"L Bobby","year":"2020","unstructured":"Bobby L, Mirabella Z, Ida V, Johan BJCGH. The risk of extraintestinal cancer in inflammatory bowel disease: a systematic review and meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2020;19:1117\u2013113819. https:\/\/doi.org\/10.1016\/j.cgh.2020.08.015.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2038_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1038\/ajg.2016.239","volume":"111","author":"W Li-Hui","year":"2016","unstructured":"Li-Hui W, et al. Higher risk for hematological malignancies in inflammatory bowel disease: a nationwide population-based study in Taiwan. Off J Am Coll Gastroenterol. 2016;111:1313\u20139. https:\/\/doi.org\/10.1038\/ajg.2016.239.","journal-title":"Off J Am Coll Gastroenterol"},{"key":"2038_CR25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/gut.2004.051771","volume":"54","author":"J Askling","year":"2005","unstructured":"Askling J, et al. Risk of haematopoietic cancer in patients with inflammatory bowel disease. Gut. 2005;54:617\u201322. https:\/\/doi.org\/10.1136\/gut.2004.051771.","journal-title":"Gut"},{"key":"2038_CR26","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1093\/ecco-jcc\/jjx040","volume":"11","author":"Y Jung","year":"2017","unstructured":"Jung Y, et al. Cancer risk in the early stages of inflammatory bowel disease in Korean patients: a nationwide population-based study. J Crohn\u2019s Colitis. 2017;11:954\u201362. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjx040.","journal-title":"J Crohn's Colitis"},{"key":"2038_CR27","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/j.cgh.2014.08.025","volume":"13","author":"P Deepak","year":"2015","unstructured":"Deepak P, Stobaugh DJ. Risk of myeloid neoplasms in inflammatory bowel disease patients is linked to exposure to thiopurines and not with tumor necrosis factor-alpha inhibitors. Clin Gastroenterol Hepatol. 2015;13:1857\u20138. https:\/\/doi.org\/10.1016\/j.cgh.2014.08.025.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2038_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/bjh.15163","volume":"181","author":"LSG \u00d8stg\u00e5rd","year":"2018","unstructured":"\u00d8stg\u00e5rd LSG, et al. Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population-based case-control study. Br J Haematol. 2018;181:205\u201314. https:\/\/doi.org\/10.1111\/bjh.15163.","journal-title":"Br J Haematol"},{"key":"2038_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.14309\/ajg.0000000000001058","volume":"116","author":"K Nabeel","year":"2021","unstructured":"Nabeel K, et al. Incidence of acute myeloid leukemia and myelodysplastic syndrome in patients with inflammatory bowel disease and the impact of thiopurines on their risk. Off J Am Coll Gastroenterol. 2021;116:741\u20137.","journal-title":"Off J Am Coll Gastroenterol"},{"key":"2038_CR30","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cgh.2014.02.026","volume":"12","author":"L Anthony","year":"2014","unstructured":"Anthony L, et al. Increased risk of acute myeloid leukemias and myelodysplastic syndromes in patients who received thiopurine treatment for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2014;12:1324\u20139. https:\/\/doi.org\/10.1016\/j.cgh.2014.02.026.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2038_CR31","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s00535-013-0873-3","volume":"49","author":"N Fukata","year":"2014","unstructured":"Fukata N, Okazaki K, Omiya M, Matsushita M, Watanabe M. Hematologic malignancies in the Japanese patients with inflammatory bowel disease. J Gastroenterol. 2014;49:1299\u2013306. https:\/\/doi.org\/10.1007\/s00535-013-0873-3.","journal-title":"J Gastroenterol"},{"key":"2038_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. \u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1\u201322. https:\/\/doi.org\/10.1093\/ije\/dyg070.","journal-title":"Int J Epidemiol"},{"key":"2038_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","volume":"10","author":"J Bowden","year":"2019","unstructured":"Bowden J, Holmes MV. Meta-analysis and Mendelian randomization: a review. Res Synth Methods. 2019;10:486\u201396. https:\/\/doi.org\/10.1002\/jrsm.1346.","journal-title":"Res Synth Methods"},{"key":"2038_CR34","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, et al. Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614\u201321. https:\/\/doi.org\/10.1001\/jama.2021.18236.","journal-title":"JAMA"},{"key":"2038_CR35","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet. 2018;50:693\u20138. https:\/\/doi.org\/10.1038\/s41588-018-0099-7.","journal-title":"Nat Genet"},{"key":"2038_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32:377\u201389. https:\/\/doi.org\/10.1007\/s10654-017-0255-x.","journal-title":"Eur J Epidemiol"},{"key":"2038_CR37","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"2038_CR38","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. https:\/\/doi.org\/10.1186\/1471-2105-9-559.","journal-title":"BMC Bioinform"},{"key":"2038_CR39","doi-asserted-by":"publisher","first-page":"W60","DOI":"10.1093\/nar\/gky311","volume":"46","author":"M Franz","year":"2018","unstructured":"Franz M, et al. GeneMANIA update 2018. Nucleic Acids Res. 2018;46:W60-w64. https:\/\/doi.org\/10.1093\/nar\/gky311.","journal-title":"Nucleic Acids Res"},{"key":"2038_CR40","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis G Jr, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4:P3.","journal-title":"Genome Biol"},{"key":"2038_CR41","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","volume":"46","author":"H Han","year":"2018","unstructured":"Han H, et al. TRRUST v2: an expanded reference database of human and mouse transcriptional regulatory interactions. Nucleic Acids Res. 2018;46:D380-d386. https:\/\/doi.org\/10.1093\/nar\/gkx1013.","journal-title":"Nucleic Acids Res"},{"key":"2038_CR42","doi-asserted-by":"publisher","first-page":"20144","DOI":"10.1038\/s41598-022-24306-2","volume":"12","author":"N Daneshafrooz","year":"2022","unstructured":"Daneshafrooz N, Bagherzadeh Cham M, Majidi M, Panahi B. Identification of potentially functional modules and diagnostic genes related to amyotrophic lateral sclerosis based on the WGCNA and LASSO algorithms. Sci Rep. 2022;12:20144. https:\/\/doi.org\/10.1038\/s41598-022-24306-2.","journal-title":"Sci Rep"},{"key":"2038_CR43","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin X, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. https:\/\/doi.org\/10.1186\/1471-2105-12-77.","journal-title":"BMC Bioinform"},{"key":"2038_CR44","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","volume":"1711","author":"B Chen","year":"2018","unstructured":"Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243\u201359. https:\/\/doi.org\/10.1007\/978-1-4939-7493-1_12.","journal-title":"Methods Mol Biol"},{"key":"2038_CR45","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinform"},{"key":"2038_CR46","doi-asserted-by":"publisher","first-page":"e19422","DOI":"10.7759\/cureus.19422","volume":"13","author":"A Messori","year":"2021","unstructured":"Messori A. Synthetizing published evidence on survival by reconstruction of patient-level data and generation of a multi-trial Kaplan-Meier curve. Cureus. 2021;13:e19422. https:\/\/doi.org\/10.7759\/cureus.19422.","journal-title":"Cureus"},{"key":"2038_CR47","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics. 2015;31:3069\u201371. https:\/\/doi.org\/10.1093\/bioinformatics\/btv313.","journal-title":"Bioinformatics"},{"key":"2038_CR48","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1073\/pnas.78.4.2179","volume":"78","author":"HR Drew","year":"1981","unstructured":"Drew HR, et al. Structure of a B-DNA dodecamer: conformation and dynamics. Proc Natl Acad Sci U S A. 1981;78:2179\u201383. https:\/\/doi.org\/10.1073\/pnas.78.4.2179.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2038_CR49","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1093\/bioinformatics\/btz459","volume":"35","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Sanner MF. AutoDock CrankPep: combining folding and docking to predict protein-peptide complexes. Bioinformatics. 2019;35:5121\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/btz459.","journal-title":"Bioinformatics"},{"key":"2038_CR50","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","volume":"61","author":"J Eberhardt","year":"2021","unstructured":"Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: new docking methods, expanded force field, and python bindings. J Chem Inf Model. 2021;61:3891\u20138. https:\/\/doi.org\/10.1021\/acs.jcim.1c00203.","journal-title":"J Chem Inf Model"},{"key":"2038_CR51","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10822-010-9352-6","volume":"24","author":"D Seeliger","year":"2010","unstructured":"Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock\/Vina. J Comput Aided Mol Des. 2010;24:417\u201322. https:\/\/doi.org\/10.1007\/s10822-010-9352-6.","journal-title":"J Comput Aided Mol Des"},{"key":"2038_CR52","doi-asserted-by":"publisher","first-page":"1221272","DOI":"10.3389\/fnagi.2023.1221272","volume":"15","author":"M Yu","year":"2023","unstructured":"Yu M, Li Y, Li B, Ge Q. Inflammatory biomarkers and delirium: a Mendelian randomization study. Front Aging Neurosci. 2023;15:1221272. https:\/\/doi.org\/10.3389\/fnagi.2023.1221272.","journal-title":"Front Aging Neurosci"},{"key":"2038_CR53","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1002\/ijc.34300","volume":"152","author":"H Cavalier","year":"2023","unstructured":"Cavalier H, Trasande L, Porta M. Exposures to pesticides and risk of cancer: evaluation of recent epidemiological evidence in humans and paths forward. Int J Cancer. 2023;152:879\u2013912. https:\/\/doi.org\/10.1002\/ijc.34300.","journal-title":"Int J Cancer"},{"key":"2038_CR54","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/mop.0000000000000855","volume":"32","author":"CW Elgarten","year":"2020","unstructured":"Elgarten CW, Aplenc R. Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy. Curr Opin Pediatr. 2020;32:57\u201366. https:\/\/doi.org\/10.1097\/mop.0000000000000855.","journal-title":"Curr Opin Pediatr"},{"key":"2038_CR55","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1080\/10428194.2017.1312377","volume":"58","author":"N Shanmuganathan","year":"2017","unstructured":"Shanmuganathan N, Hiwase DK, Ross DM. Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome. Leuk Lymphoma. 2017;58:2799\u2013810. https:\/\/doi.org\/10.1080\/10428194.2017.1312377.","journal-title":"Leuk Lymphoma"},{"key":"2038_CR56","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12929-020-00674-7","volume":"27","author":"HA Hou","year":"2020","unstructured":"Hou HA, Tien HF. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies. J Biomed Sci. 2020;27:81. https:\/\/doi.org\/10.1186\/s12929-020-00674-7.","journal-title":"J Biomed Sci"},{"key":"2038_CR57","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/ijc.33932","volume":"150","author":"H Zhang","year":"2022","unstructured":"Zhang H, et al. Risk of malignancy in patients with inflammatory bowel disease: a population-based cohort study from China. Int J Cancer. 2022;150:1770\u20138. https:\/\/doi.org\/10.1002\/ijc.33932.","journal-title":"Int J Cancer"},{"key":"2038_CR58","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1007\/s10552-012-9977-y","volume":"23","author":"KJ Johnson","year":"2012","unstructured":"Johnson KJ, et al. Medical conditions and risk of adult myeloid leukemia. Cancer Causes Control. 2012;23:1083\u20139. https:\/\/doi.org\/10.1007\/s10552-012-9977-y.","journal-title":"Cancer Causes Control"},{"key":"2038_CR59","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nrc3341","volume":"12","author":"BE Henderson","year":"2012","unstructured":"Henderson BE, Lee NH, Seewaldt V, Shen H. The influence of race and ethnicity on the biology of cancer. Nat Rev Cancer. 2012;12:648\u201353. https:\/\/doi.org\/10.1038\/nrc3341.","journal-title":"Nat Rev Cancer"},{"key":"2038_CR60","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/s12916-024-03352-9","volume":"22","author":"D Liu","year":"2024","unstructured":"Liu D, et al. Association between inflammatory bowel disease and cancer risk: evidence triangulation from genetic correlation, Mendelian randomization, and colocalization analyses across East Asian and European populations. BMC Med. 2024;22:137. https:\/\/doi.org\/10.1186\/s12916-024-03352-9.","journal-title":"BMC Med"},{"key":"2038_CR61","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/jgh.12189","volume":"28","author":"Y Yano","year":"2013","unstructured":"Yano Y, et al. Cancer risk in Japanese Crohn\u2019s disease patients: investigation of the standardized incidence ratio. J Gastroenterol Hepatol. 2013;28:1300\u20135. https:\/\/doi.org\/10.1111\/jgh.12189.","journal-title":"J Gastroenterol Hepatol"},{"key":"2038_CR62","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.3390\/jcm11092655","volume":"11","author":"A Czajkowska","year":"2022","unstructured":"Czajkowska A, Guzinska-Ustymowicz K, Pryczynicz A, Lebensztejn D, Daniluk U. Are matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 useful as markers in diagnostic management of children with newly diagnosed ulcerative colitis? J Clin Med. 2022;11:2655. https:\/\/doi.org\/10.3390\/jcm11092655.","journal-title":"J Clin Med"},{"key":"2038_CR63","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000524978","volume":"90","author":"N Eiro","year":"2023","unstructured":"Eiro N, et al. Expression of MMP-2, MMP-7, MMP-9, and TIMP-1 by inflamed mucosa in the initial diagnosis of ulcerative colitis as a response marker for conventional medical treatment. Pathobiol J Immunopathol Mol Cell Biol. 2023;90:81\u201393. https:\/\/doi.org\/10.1159\/000524978.","journal-title":"Pathobiol J Immunopathol Mol Cell Biol"},{"key":"2038_CR64","doi-asserted-by":"publisher","first-page":"215863","DOI":"10.1016\/j.canlet.2022.215863","volume":"546","author":"Z Tian","year":"2022","unstructured":"Tian Z, et al. TIMP1 derived from pancreatic cancer cells stimulates Schwann cells and promotes the occurrence of perineural invasion. Cancer Lett. 2022;546:215863. https:\/\/doi.org\/10.1016\/j.canlet.2022.215863.","journal-title":"Cancer Lett"},{"key":"2038_CR65","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.3324\/haematol.2017.168799","volume":"102","author":"J Vandooren","year":"2017","unstructured":"Vandooren J, et al. Endotoxemia shifts neutrophils with TIMP-free gelatinase B\/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1. Haematologica. 2017;102:1671\u201382. https:\/\/doi.org\/10.3324\/haematol.2017.168799.","journal-title":"Haematologica"},{"key":"2038_CR66","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3892\/ijmm_00000188","volume":"23","author":"S Gr\u00e4ssel","year":"2009","unstructured":"Gr\u00e4ssel S, Ahmed N, G\u00f6ttl C, Grifka J. Gene and protein expression profile of naive and osteo-chondrogenically differentiated rat bone marrow-derived mesenchymal progenitor cells. Int J Mol Med. 2009;23:745\u201355. https:\/\/doi.org\/10.3892\/ijmm_00000188.","journal-title":"Int J Mol Med"},{"key":"2038_CR67","doi-asserted-by":"publisher","first-page":"1376123","DOI":"10.3389\/fgene.2024.1376123","volume":"15","author":"MT Tran","year":"2024","unstructured":"Tran MT. Identification of TIMP1-induced dysregulation of epithelial-mesenchymal transition as a key pathway in inflammatory bowel disease and small intestinal neuroendocrine tumors shared pathogenesis. Front Genet. 2024;15:1376123. https:\/\/doi.org\/10.3389\/fgene.2024.1376123.","journal-title":"Front Genet"},{"key":"2038_CR68","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1136\/gut.2008.163667","volume":"58","author":"S Brand","year":"2009","unstructured":"Brand S. Crohn\u2019s disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn\u2019s disease. Gut. 2009;58:1152\u201367. https:\/\/doi.org\/10.1136\/gut.2008.163667.","journal-title":"Gut"},{"key":"2038_CR69","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3389\/fimmu.2019.01177","volume":"10","author":"M Bsat","year":"2019","unstructured":"Bsat M, et al. Differential pathogenic Th17 profile in mesenteric lymph nodes of Crohn\u2019s disease and ulcerative colitis patients. Front Immunol. 2019;10:1177. https:\/\/doi.org\/10.3389\/fimmu.2019.01177.","journal-title":"Front Immunol"},{"key":"2038_CR70","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1158\/2159-8290.Cd-24-0134","volume":"15","author":"N Priego","year":"2025","unstructured":"Priego N, et al. TIMP1 mediates astrocyte-dependent local immunosuppression in brain metastasis acting on infiltrating CD8+ T cells. Cancer Discov. 2025;15:179\u2013201. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0134.","journal-title":"Cancer Discov"},{"key":"2038_CR71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/2159-8290.Cd-24-1495","volume":"15","author":"M Lorger","year":"2025","unstructured":"Lorger M, James F. Taking a swing at TIMP1-armed immunosuppressive astrocytes unleashes T cell immunity against brain metastases. Cancer Discov. 2025;15:11\u20133. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-1495.","journal-title":"Cancer Discov"},{"key":"2038_CR72","doi-asserted-by":"publisher","first-page":"e120974","DOI":"10.1172\/jci.insight.120974","volume":"3","author":"HA Knaus","year":"2018","unstructured":"Knaus HA, et al. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. JCI insight. 2018;3:e120974. https:\/\/doi.org\/10.1172\/jci.insight.120974.","journal-title":"JCI insight"},{"key":"2038_CR73","doi-asserted-by":"publisher","first-page":"438","DOI":"10.22034\/iji.2023.97902.2537","volume":"20","author":"M Mohammadi","year":"2023","unstructured":"Mohammadi M, et al. Evaluation of mRNA expressions of TOX and NR4As in CD8+ T cells in acute leukemia. Iran J Immunol IJI. 2023;20:438\u201345. https:\/\/doi.org\/10.22034\/iji.2023.97902.2537.","journal-title":"Iran J Immunol IJI"},{"key":"2038_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-021-00265-0","volume":"9","author":"R Guo","year":"2021","unstructured":"Guo R, et al. Single-cell map of diverse immune phenotypes in the acute myeloid leukemia microenvironment. Biomarker Res. 2021;9:15. https:\/\/doi.org\/10.1186\/s40364-021-00265-0.","journal-title":"Biomarker Res"},{"key":"2038_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-019-0306-1","volume":"17","author":"K Nakamura","year":"2020","unstructured":"Nakamura K, Smyth MJ. Myeloid immunosuppression and immune checkpoints in the tumor microenvironment. Cell Mol Immunol. 2020;17:1\u201312. https:\/\/doi.org\/10.1038\/s41423-019-0306-1.","journal-title":"Cell Mol Immunol"},{"key":"2038_CR76","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.molimm.2018.07.016","volume":"101","author":"J Qi","year":"2018","unstructured":"Qi J, et al. Myeloid-derived suppressor cells exacerbate Sj\u00f6gren\u2019s syndrome by inhibiting Th2 immune responses. Mol Immunol. 2018;101:251\u20138. https:\/\/doi.org\/10.1016\/j.molimm.2018.07.016.","journal-title":"Mol Immunol"},{"key":"2038_CR77","doi-asserted-by":"publisher","first-page":"868695","DOI":"10.3389\/fphar.2022.868695","volume":"13","author":"SK Kim","year":"2022","unstructured":"Kim SK, Cho SW. The evasion mechanisms of cancer immunity and drug intervention in the tumor microenvironment. Front Pharmacol. 2022;13:868695. https:\/\/doi.org\/10.3389\/fphar.2022.868695.","journal-title":"Front Pharmacol"},{"key":"2038_CR78","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1182\/blood-2016-07-730614","volume":"129","author":"AR Pyzer","year":"2017","unstructured":"Pyzer AR, et al. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia. Blood. 2017;129:1791\u2013801. https:\/\/doi.org\/10.1182\/blood-2016-07-730614.","journal-title":"Blood"},{"key":"2038_CR79","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s12943-019-1102-3","volume":"18","author":"X Li","year":"2019","unstructured":"Li X, et al. Harnessing tumor-associated macrophages as aids for cancer immunotherapy. Mol Cancer. 2019;18:177. https:\/\/doi.org\/10.1186\/s12943-019-1102-3.","journal-title":"Mol Cancer"},{"key":"2038_CR80","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1182\/blood.2019003990","volume":"136","author":"K Wu","year":"2020","unstructured":"Wu K, et al. The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice. Blood. 2020;136:501\u201315. https:\/\/doi.org\/10.1182\/blood.2019003990.","journal-title":"Blood"},{"key":"2038_CR81","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","volume":"38","author":"M Klichinsky","year":"2020","unstructured":"Klichinsky M, et al. Human chimeric antigen receptor macrophages for cancer immunotherapy. Nat Biotechnol. 2020;38:947\u201353. https:\/\/doi.org\/10.1038\/s41587-020-0462-y.","journal-title":"Nat Biotechnol"},{"key":"2038_CR82","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41419-022-05336-0","volume":"13","author":"X Rao","year":"2022","unstructured":"Rao X, et al. NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer. Cell Death Dis. 2022;13:891. https:\/\/doi.org\/10.1038\/s41419-022-05336-0.","journal-title":"Cell Death Dis"},{"key":"2038_CR83","doi-asserted-by":"publisher","first-page":"1146693","DOI":"10.3389\/fimmu.2023.1146693","volume":"14","author":"S Hou","year":"2023","unstructured":"Hou S, Wang D, Yuan X, Yuan X, Yuan Q. Identification of biomarkers co-associated with M1 macrophages, ferroptosis and cuproptosis in alcoholic hepatitis by bioinformatics and experimental verification. Front Immunol. 2023;14:1146693. https:\/\/doi.org\/10.3389\/fimmu.2023.1146693.","journal-title":"Front Immunol"},{"key":"2038_CR84","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/mib.0000000000000384","volume":"21","author":"D Lissner","year":"2015","unstructured":"Lissner D, et al. Monocyte and M1 macrophage-induced barrier defect contributes to chronic intestinal inflammation in IBD. Inflamm Bowel Dis. 2015;21:1297\u2013305. https:\/\/doi.org\/10.1097\/mib.0000000000000384.","journal-title":"Inflamm Bowel Dis"},{"key":"2038_CR85","doi-asserted-by":"publisher","first-page":"692800","DOI":"10.3389\/fcell.2021.692800","volume":"9","author":"KE Miari","year":"2021","unstructured":"Miari KE, Guzman ML, Wheadon H, Williams MTS. Macrophages in acute myeloid leukaemia: significant players in therapy resistance and patient outcomes. Front Cell Dev Biol. 2021;9:692800. https:\/\/doi.org\/10.3389\/fcell.2021.692800.","journal-title":"Front Cell Dev Biol"},{"key":"2038_CR86","doi-asserted-by":"publisher","first-page":"1683347","DOI":"10.1080\/2162402x.2019.1683347","volume":"9","author":"ZJ Xu","year":"2020","unstructured":"Xu ZJ, et al. The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia. Oncoimmunology. 2020;9:1683347. https:\/\/doi.org\/10.1080\/2162402x.2019.1683347.","journal-title":"Oncoimmunology"},{"key":"2038_CR87","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.18632\/oncotarget.13664","volume":"8","author":"D Forte","year":"2017","unstructured":"Forte D, et al. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63\/PI3K\/Akt\/p21 signaling. Oncotarget. 2017;8:2261\u201374. https:\/\/doi.org\/10.18632\/oncotarget.13664.","journal-title":"Oncotarget"},{"key":"2038_CR88","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1042\/bj20030187","volume":"372","author":"E Lambert","year":"2003","unstructured":"Lambert E, et al. Tissue inhibitor of metalloproteinases-1 signalling pathway leading to erythroid cell survival. Biochem J. 2003;372:767\u201374. https:\/\/doi.org\/10.1042\/bj20030187.","journal-title":"Biochem J"},{"key":"2038_CR89","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s41588-023-01480-1","volume":"55","author":"A Rodriguez-Meira","year":"2023","unstructured":"Rodriguez-Meira A, et al. Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution. Nat Genet. 2023;55:1531\u201341. https:\/\/doi.org\/10.1038\/s41588-023-01480-1.","journal-title":"Nat Genet"},{"key":"2038_CR90","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.tcb.2022.08.005","volume":"33","author":"B Schoeps","year":"2023","unstructured":"Schoeps B, Fr\u00e4drich J, Kr\u00fcger A. Cut loose TIMP-1: an emerging cytokine in inflammation. Trends Cell Biol. 2023;33:413\u201326. https:\/\/doi.org\/10.1016\/j.tcb.2022.08.005.","journal-title":"Trends Cell Biol"},{"key":"2038_CR91","doi-asserted-by":"publisher","first-page":"e59367","DOI":"10.1371\/journal.pone.0059367","volume":"8","author":"A Adamson","year":"2013","unstructured":"Adamson A, et al. Tissue inhibitor of metalloproteinase 1 is preferentially expressed in Th1 and Th17 T-helper cell subsets and is a direct STAT target gene. PLoS ONE. 2013;8:e59367. https:\/\/doi.org\/10.1371\/journal.pone.0059367.","journal-title":"PLoS ONE"},{"key":"2038_CR92","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1749-6632.2009.05133.x","volume":"1183","author":"JM Damsker","year":"2010","unstructured":"Damsker JM, Hansen AM, Caspi RR. Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci. 2010;1183:211\u201321. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05133.x.","journal-title":"Ann N Y Acad Sci"},{"key":"2038_CR93","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1182\/blood-2018-03-784116","volume":"132","author":"L Barreyro","year":"2018","unstructured":"Barreyro L, Chlon TM, Starczynowski DT. Chronic immune response dysregulation in MDS pathogenesis. Blood. 2018;132:1553\u201360. https:\/\/doi.org\/10.1182\/blood-2018-03-784116.","journal-title":"Blood"},{"key":"2038_CR94","doi-asserted-by":"publisher","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","volume":"18","author":"A Carey","year":"2017","unstructured":"Carey A, et al. Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia. Cell Rep. 2017;18:3204\u201318. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.018.","journal-title":"Cell Rep"},{"key":"2038_CR95","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/2159-8290.Cd-21-1146","volume":"12","author":"A Yeaton","year":"2022","unstructured":"Yeaton A, et al. The impact of inflammation-induced tumor plasticity during myeloid transformation. Cancer Discov. 2022;12:2392\u2013413. https:\/\/doi.org\/10.1158\/2159-8290.Cd-21-1146.","journal-title":"Cancer Discov"},{"key":"2038_CR96","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","volume":"21","author":"SA Lasser","year":"2024","unstructured":"Lasser SA, Ozbay Kurt FG, Arkhypov I, Utikal J, Umansky V. Myeloid-derived suppressor cells in cancer and cancer therapy. Nat Rev Clin Oncol. 2024;21:147\u201364. https:\/\/doi.org\/10.1038\/s41571-023-00846-y.","journal-title":"Nat Rev Clin Oncol"},{"key":"2038_CR97","doi-asserted-by":"publisher","first-page":"e004384","DOI":"10.1136\/jitc-2021-004384","volume":"10","author":"R Bitsch","year":"2022","unstructured":"Bitsch R, et al. STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice. J Immunother Cancer. 2022;10:e004384. https:\/\/doi.org\/10.1136\/jitc-2021-004384.","journal-title":"J Immunother Cancer"},{"key":"2038_CR98","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/0300985820963087","volume":"58","author":"K Kaji","year":"2021","unstructured":"Kaji K, et al. Protease-activated receptor-2 is associated with adverse outcomes in canine mammary carcinoma. Vet Pathol. 2021;58:53\u201362. https:\/\/doi.org\/10.1177\/0300985820963087.","journal-title":"Vet Pathol"},{"key":"2038_CR99","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/pai.0000000000001025","volume":"30","author":"G Kapatia","year":"2022","unstructured":"Kapatia G, et al. Expression of proteinase-activated receptor 2 (PAR2) as a correlate of concern in triple-negative breast cancer (TNBC). Appl Immunohistochem Mol Morphol. 2022;30:446\u201352. https:\/\/doi.org\/10.1097\/pai.0000000000001025.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2038_CR100","doi-asserted-by":"publisher","first-page":"e94993","DOI":"10.1371\/journal.pone.0094993","volume":"9","author":"N B\u00e4umer","year":"2014","unstructured":"B\u00e4umer N, et al. Proteinase-activated receptor 1 (PAR1) regulates leukemic stem cell functions. PLoS ONE. 2014;9:e94993. https:\/\/doi.org\/10.1371\/journal.pone.0094993.","journal-title":"PLoS ONE"},{"key":"2038_CR101","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1038\/bcj.2016.36","volume":"6","author":"A Maiga","year":"2016","unstructured":"Maiga A, et al. Transcriptome analysis of G protein-coupled receptors in distinct genetic subgroups of acute myeloid leukemia: identification of potential disease-specific targets. Blood Cancer J. 2016;6:e431. https:\/\/doi.org\/10.1038\/bcj.2016.36.","journal-title":"Blood Cancer J"},{"key":"2038_CR102","first-page":"6575","volume":"63","author":"K Yamashita","year":"2003","unstructured":"Yamashita K, Mimori K, Inoue H, Mori M, Sidransky D. A tumor-suppressive role for trypsin in human cancer progression. Cancer Res. 2003;63:6575\u20138.","journal-title":"Cancer Res"},{"key":"2038_CR103","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s007020170083","volume":"108","author":"T Okamoto","year":"2001","unstructured":"Okamoto T, et al. The effects of stimulating protease-activated receptor-1 and -2 in A172 human glioblastoma. J Neural Transm (Vienna). 2001;108:125\u201340. https:\/\/doi.org\/10.1007\/s007020170083.","journal-title":"J Neural Transm (Vienna)"},{"key":"2038_CR104","doi-asserted-by":"publisher","first-page":"G30","DOI":"10.1152\/ajpgi.00203.2020","volume":"320","author":"JY Her","year":"2021","unstructured":"Her JY, et al. Blockage of protease-activated receptor 2 exacerbates inflammation in high-fat environment partly through autophagy inhibition. Am J Physiol Gastrointest Liver Physiol. 2021;320:G30-g42. https:\/\/doi.org\/10.1152\/ajpgi.00203.2020.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2038_CR105","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1182\/blood-2005-05-1875","volume":"107","author":"E Csernok","year":"2006","unstructured":"Csernok E, et al. Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway. Blood. 2006;107:4440\u20138. https:\/\/doi.org\/10.1182\/blood-2005-05-1875.","journal-title":"Blood"},{"key":"2038_CR106","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fimmu.2016.00070","volume":"7","author":"F Benvenuti","year":"2016","unstructured":"Benvenuti F. The dendritic cell synapse: a life dedicated to T cell activation. Front Immunol. 2016;7:70. https:\/\/doi.org\/10.3389\/fimmu.2016.00070.","journal-title":"Front Immunol"},{"key":"2038_CR107","doi-asserted-by":"publisher","first-page":"e1391","DOI":"10.1002\/ctm2.1391","volume":"13","author":"E Dantas","year":"2023","unstructured":"Dantas E, et al. TIMP1 is an early biomarker for detection and prognosis of lung cancer. Clin Transl Med. 2023;13:e1391. https:\/\/doi.org\/10.1002\/ctm2.1391.","journal-title":"Clin Transl Med"},{"key":"2038_CR108","doi-asserted-by":"publisher","first-page":"648134","DOI":"10.3389\/fgene.2022.648134","volume":"13","author":"Y Shou","year":"2022","unstructured":"Shou Y, et al. TIMP1 indicates poor prognosis of renal cell carcinoma and accelerates tumorigenesis via EMT signaling pathway. Front Genet. 2022;13:648134. https:\/\/doi.org\/10.3389\/fgene.2022.648134.","journal-title":"Front Genet"},{"key":"2038_CR109","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/nm.2415","volume":"17","author":"K Eppert","year":"2011","unstructured":"Eppert K, et al. Stem cell gene expression programs influence clinical outcome in human leukemia. Nat Med. 2011;17:1086\u201393. https:\/\/doi.org\/10.1038\/nm.2415.","journal-title":"Nat Med"},{"key":"2038_CR110","doi-asserted-by":"publisher","first-page":"1202825","DOI":"10.3389\/fimmu.2023.1202825","volume":"14","author":"Y Huang","year":"2023","unstructured":"Huang Y, et al. A novel stemness classification in acute myeloid leukemia by the stemness index and the identification of cancer stem cell-related biomarkers. Front Immunol. 2023;14:1202825. https:\/\/doi.org\/10.3389\/fimmu.2023.1202825.","journal-title":"Front Immunol"},{"key":"2038_CR111","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.7314\/apjcp.2016.17.3.1519","volume":"17","author":"AK Chaudhary","year":"2016","unstructured":"Chaudhary AK, Chaudhary S, Ghosh K, Shanmukaiah C, Nadkarni AH. Secretion and expression of matrix metalloproteinase-2 and 9 from bone marrow mononuclear cells in myelodysplastic syndrome and acute myeloid leukemia. Asian Pac J Cancer Prev. 2016;17:1519\u201329. https:\/\/doi.org\/10.7314\/apjcp.2016.17.3.1519.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2038_CR112","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1186\/s12967-019-2068-z","volume":"17","author":"R Li","year":"2019","unstructured":"Li R, et al. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers. J Transl Med. 2019;17:324. https:\/\/doi.org\/10.1186\/s12967-019-2068-z.","journal-title":"J Transl Med"},{"key":"2038_CR113","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/s41416-023-02379-8","volume":"129","author":"Z Yang","year":"2023","unstructured":"Yang Z, et al. Comprehensive analysis of the lncRNAs-related immune gene signatures and their correlation with immunotherapy in lung adenocarcinoma. Br J Cancer. 2023;129:1397\u2013408. https:\/\/doi.org\/10.1038\/s41416-023-02379-8.","journal-title":"Br J Cancer"},{"key":"2038_CR114","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.2174\/1871520619666190705150214","volume":"19","author":"M Vinayak","year":"2019","unstructured":"Vinayak M, Maurya AK. Quercetin loaded nanoparticles in targeting cancer: recent development. Anticancer Agents Med Chem. 2019;19:1560\u201376. https:\/\/doi.org\/10.2174\/1871520619666190705150214.","journal-title":"Anticancer Agents Med Chem"},{"key":"2038_CR115","first-page":"235","volume":"147","author":"MA Read","year":"1995","unstructured":"Read MA. Flavonoids: naturally occurring anti-inflammatory agents. Am J Pathol. 1995;147:235\u20137.","journal-title":"Am J Pathol"},{"key":"2038_CR116","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.jep.2004.06.006","volume":"94","author":"N Orsoli\u0107","year":"2004","unstructured":"Orsoli\u0107 N, Knezevi\u0107 AH, Sver L, Terzi\u0107 S, Basi\u0107 I. Immunomodulatory and antimetastatic action of propolis and related polyphenolic compounds. J Ethnopharmacol. 2004;94:307\u201315. https:\/\/doi.org\/10.1016\/j.jep.2004.06.006.","journal-title":"J Ethnopharmacol"},{"key":"2038_CR117","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ptr.8027","volume":"38","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Quercetin ameliorates ulcerative colitis by activating aryl hydrocarbon receptor to improve intestinal barrier integrity. Phytother Res. 2024;38:253\u201364. https:\/\/doi.org\/10.1002\/ptr.8027.","journal-title":"Phytother Res"},{"key":"2038_CR118","doi-asserted-by":"publisher","first-page":"116557","DOI":"10.1016\/j.jep.2023.116557","volume":"313","author":"HF Zhou","year":"2023","unstructured":"Zhou HF, et al. Quercetin serves as the major component of Xiang-lian Pill to ameliorate ulcerative colitis via tipping the balance of STAT1\/PPAR\u03b3 and dictating the alternative activation of macrophage. J Ethnopharmacol. 2023;313:116557. https:\/\/doi.org\/10.1016\/j.jep.2023.116557.","journal-title":"J Ethnopharmacol"},{"key":"2038_CR119","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.canlet.2005.09.013","volume":"240","author":"TJ Lee","year":"2006","unstructured":"Lee TJ, et al. Quercetin arrests G2\/M phase and induces caspase-dependent cell death in U937 cells. Cancer Lett. 2006;240:234\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2005.09.013.","journal-title":"Cancer Lett"},{"key":"2038_CR120","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3892\/mmr.2015.4600","volume":"13","author":"X Chen","year":"2016","unstructured":"Chen X, et al. Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells. Mol Med Rep. 2016;13:689\u201396. https:\/\/doi.org\/10.3892\/mmr.2015.4600.","journal-title":"Mol Med Rep"},{"key":"2038_CR121","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1158\/1078-0432.Ccr-10-1565","volume":"16","author":"S Cheng","year":"2010","unstructured":"Cheng S, et al. Quercetin induces tumor-selective apoptosis through downregulation of Mcl-1 and activation of Bax. Clin Cancer Res. 2010;16:5679\u201391. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-1565.","journal-title":"Clin Cancer Res"},{"key":"2038_CR122","doi-asserted-by":"publisher","first-page":"e0263917","DOI":"10.1371\/journal.pone.0263917","volume":"17","author":"A Ghosh","year":"2022","unstructured":"Ghosh A, et al. Nonlinear molecular dynamics of quercetin in Gynocardia odorata and Diospyros malabarica fruits: its mechanistic role in hepatoprotection. PLoS ONE. 2022;17:e0263917. https:\/\/doi.org\/10.1371\/journal.pone.0263917.","journal-title":"PLoS ONE"},{"key":"2038_CR123","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbrc.2022.05.033","volume":"615","author":"S Ohmae","year":"2022","unstructured":"Ohmae S, et al. Quercetin attenuates adipogenesis and fibrosis in human skeletal muscle. Biochem Biophys Res Commun. 2022;615:24\u201330. https:\/\/doi.org\/10.1016\/j.bbrc.2022.05.033.","journal-title":"Biochem Biophys Res Commun"},{"key":"2038_CR124","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/s0027-5107(01)00184-1","volume":"480\u2013481","author":"DM Morrow","year":"2001","unstructured":"Morrow DM, Fitzsimmons PE, Chopra M, McGlynn H. Dietary supplementation with the anti-tumour promoter quercetin: its effects on matrix metalloproteinase gene regulation. Mutat Res. 2001;480\u2013481:269\u201376. https:\/\/doi.org\/10.1016\/s0027-5107(01)00184-1.","journal-title":"Mutat Res"},{"key":"2038_CR125","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3389\/fpls.2015.00655","volume":"6","author":"I Jantan","year":"2015","unstructured":"Jantan I, Ahmad W, Bukhari SN. Plant-derived immunomodulators: an insight on their preclinical evaluation and clinical trials. Front Plant Sci. 2015;6:655. https:\/\/doi.org\/10.3389\/fpls.2015.00655.","journal-title":"Front Plant Sci"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02038-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02038-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:52:38Z","timestamp":1767199958000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02038-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,30]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2038"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02038-z","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,30]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was not required for this study as all datasets used were publicly available and had already undergone ethical scrutiny during their original publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"77"}}